Globe Life (NYSE:GL) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Globe Life (NYSE:GLGet Free Report) announced its quarterly earnings data on Monday. The company reported $2.78 earnings per share for the quarter, missing the consensus estimate of $2.79 by ($0.01), Briefing.com reports. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Globe Life had a return on equity of 23.91% and a net margin of 18.07%. The company’s revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.53 earnings per share. Globe Life updated its FY24 guidance to $11.50-12.00 EPS and its FY 2024 guidance to 11.500-12.000 EPS.

Globe Life Stock Performance

Shares of GL opened at $75.79 on Wednesday. The business’s fifty day moving average price is $109.59 and its 200 day moving average price is $116.08. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00. The stock has a market capitalization of $7.13 billion, a PE ratio of 7.24 and a beta of 0.69. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.05 and a quick ratio of 0.05.

Globe Life Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Friday, April 5th will be paid a dividend of $0.24 per share. The ex-dividend date is Thursday, April 4th. This is a boost from Globe Life’s previous quarterly dividend of $0.23. This represents a $0.96 annualized dividend and a yield of 1.27%. Globe Life’s dividend payout ratio (DPR) is 9.17%.

Wall Street Analysts Forecast Growth

GL has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of Globe Life from $146.00 to $132.00 and set an “overweight” rating for the company in a research report on Thursday, April 11th. StockNews.com downgraded shares of Globe Life from a “buy” rating to a “hold” rating in a research report on Saturday. Piper Sandler dropped their target price on shares of Globe Life from $143.00 to $130.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Truist Financial reissued a “hold” rating and set a $125.00 target price on shares of Globe Life in a research report on Friday, April 12th. Finally, Evercore ISI dropped their target price on shares of Globe Life from $125.00 to $75.00 and set an “in-line” rating for the company in a research report on Friday, April 12th. Five investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $124.22.

Check Out Our Latest Report on GL

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

See Also

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.